Constitutive activation of Gαq signaling by mutations in GNAQ or GNA11 occurs in over 80% of uveal melanomas (UMs) and activates MAPK. Protein kinase C (PKC) has been implicated as a link, but the mechanistic details remained unclear. We identified PKC δ and ɛ as required and sufficient to activate MAPK in GNAQ mutant melanomas. MAPK activation depends on Ras and is caused by RasGRP3, which is significantly and selectively overexpressed in response to GNAQ/11 mutation in UM. RasGRP3 activation occurs via PKC δ- and ɛ-dependent phosphorylation and PKC-independent, DAG-mediated membrane recruitment, possibly explaining the limited effect of PKC inhibitors to durably suppress MAPK in UM. The findings nominate RasGRP3 as a therapeutic target for cancers driven by oncogenic GNAQ/11.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499527 | PMC |
| http://dx.doi.org/10.1016/j.ccell.2017.04.002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors.
Eur J Cancer
January 2025
Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Background: Metastatic uveal melanoma (mUM) is rare. Immune checkpoint inhibitors (ICIs) have shown modest efficacy in mUM. Tebentafusp prolonged overall survival (OS) in a phase 3 study.
View Article and Find Full Text PDFClinical benefit with tebentafusp in a patient with GNAQ mutant metastatic blue nevus-associated melanoma.
J Immunother Cancer
November 2024
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Melanoma arising in association with a blue nevus (BN) is rare but has molecular similarities to uveal melanoma (UM), including GNAQ/11 mutations. Tebentafusp was recently approved for UM based on improved overall survival in a phase 3 study. We hypothesized that tebentafusp may be active in BN-associated melanoma.
View Article and Find Full Text PDFNeuropeptide Precursor VGF Promotes Liver Metastatic Colonization of Gαq Mutant Uveal Melanoma by Facilitating Tumor Microenvironment via Paracrine Loops.
Adv Sci (Weinh)
December 2024
National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China.
Uveal melanoma (UM), the predominant primary ocular malignancy, often progresses to liver metastasis with limited therapeutic options. The interplay of the tumor microenvironment, encompassing secreted soluble factors, plays a crucial role in facilitating liver metastasis. In this study, the role is elucidated of the neural growth factor-inducible gene (VGF), a secreted neuropeptide precursor, in Gαq mutant UM.
View Article and Find Full Text PDF[Uveal Melanoma: Molecular and Genetic Mechanisms of Development and Therapeutic Approaches].
Mol Biol (Mosk)
October 2024
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk, 630090 Russia.
Article Synopsis
- * The cancer's molecular mechanisms are not well understood, but mutations in the GNAQ and GNA11 genes are prevalent, and a specific signaling pathway is crucial for tumor development.
- * Current therapies for metastatic uveal melanoma (MUM) are limited, though research is focused on targeted drugs and immunotherapies, with an emphasis on identifying genetic mutations for predicting metastasis risk and guiding treatment decisions.
NRAS-driven atypical melanocytic tumor with blue nevus-like morphology: A case report.
J Cutan Pathol
December 2024
Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Sunto, Japan.
Article Synopsis
- - NRAS Q61 mutations are common in melanocytic nevi and were found in a unique case of a 71-year-old Japanese man with a melanocytic tumor that had characteristics similar to a blue nevus.
- - Histopathological analysis showed dense spindle-shaped melanocytes, with additional features like hyperpigmentation and mild nuclear atypia; targeted RNA sequencing confirmed two mutations (NRAS c.182A>G and FGFR2 c.-157A>G) without other significant alterations.
- - Despite presenting similar morphology to a compound-type blue nevus ("Kamino nevus"), the tumor genetically aligns more closely with conventional melanocytic nevi driven by NRAS mutations, lacking the coexistence of ID
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!